Depakene and Lymphangiosis carcinomatosa - a phase IV clinical study of FDA data
No or too few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or too few reports are found.
What is Depakene?
Depakene has active ingredients of valproic acid. It is used in epilepsy. Currently, eHealthMe is studying from 14,719 Depakene users.
What is Lymphangiosis Carcinomatosa?
Lymphangiosis carcinomatosa (inflammation of the lymph vessels can lead to cancer) is found to be associated with 461 drugs and 249 conditions by eHealthMe. Currently, we are studying 1,398 people who have Lymphangiosis carcinomatosa.
Do you take Depakene and have Lymphangiosis carcinomatosa?Check whether Lymphangiosis carcinomatosa is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Depakene side effects by duration, gender and age:
- Depakene side effects (14,719 reports)
Lymphangiosis carcinomatosa treatments and more:
- Lymphangiosis carcinomatosa (1,398 reports)
All the drugs that are associated with Lymphangiosis carcinomatosa:
All the conditions that are associated with Lymphangiosis carcinomatosa:
How the study uses the data?
The study uses data from the FDA. It is based on valproic acid (the active ingredients of Depakene) and Depakene (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Glucagen and Glycolax drug interaction - 4 seconds ago
- Aloxi and Fluid Intake Reduced - 6 seconds ago
- Quinidine Sulfate and Revlimid drug interaction - 10 seconds ago
- Delestrogen and Aseptic Necrosis - 11 seconds ago
- Amlodipine and Fungal Oesophagitis - 12 seconds ago
- Meropenem and Transplant Rejection - 13 seconds ago
- Ondansetron and Foaming At Mouth - 18 seconds ago
- Boniva and Polyp Colorectal - 19 seconds ago
- Sulfatrim and Uptravi drug interaction - 21 seconds ago
- Asacol Hd and Ulcerative Colitis - 21 seconds ago